Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
Lindsey Hathaway,1 Jeremy Michael Sen,2 Michael Keng1 1Department of Medicine, Division of Hematology/Oncology, 2Department of Pharmacy Services, University of Virginia, Charlottesville, VA, USA Abstract: Relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) is associated with a poor prognosi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | Patient Related Outcome Measures |
| Subjects: | |
| Online Access: | https://www.dovepress.com/impact-of-blinatumomab-on-patient-outcomes-in-relapsedrefractory-acute-peer-reviewed-article-PROM |